ÌÇÐÄÆƽâ°æ

Share of research and development expenditure in overall operating revenue of Jiangsu Hengrui Pharmaceuticals Co., Ltd. from 2016 to 2024

© ÌÇÐÄÆƽâ°æ 2026
Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Release date

March 2025

Region

China

Survey time period

2016 to 2024

Supplementary notes

Figures prior to 2024 have been retrieved from the previous publications.
Figures have been rounded for a better understanding.

Citation formats

Share of R&D spending in revenue of Jiangsu Hengrui Pharmaceuticals 2016-2024

Published by A. Minhas, Jun 30, 2025

In 2024, the Chinese pharmaceutical giant Jiangsu Hengrui Pharmaceuticals spent more than * yuan on research and development, representing more than ** percent of its overall operating income. As the leading developer of oncology medicine, the company's R&D spending increased by almost *** percent between 2016 and 2024.

Log in or register to access precise data.
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

  • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 99 users
Talk to sales for pricing
Contact us
  • Free + Premium Statistics
  • Reports
  • Market ÌÇÐÄÆƽâ°æ

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Jiangsu Hengrui Pharmaceuticals "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Jiangsu Hengrui Pharmaceuticals

Company positioning

6

Key company data

8

Research and development

5

Competitors

5

The oncology drug market

4

Further Content: You might find this interesting as well

Topics

Hengrui PharmaceuticalsMedical technology in ChinaPfizerJohnson & JohnsonPharmaceutical industry in Japan
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

  • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 99 users
Talk to sales for pricing
Contact us
  • Free + Premium Statistics
  • Reports
  • Market ÌÇÐÄÆƽâ°æ

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.